This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hancock, E. Articles by Osborne, J. P. Search for Related Content PubMed PubMed Citation Articles by Hancock, E. Articles by Osborne, J. P. Social Bookmarking                   What's this?

Melatonin Excretion in Normal Children and in Tuberous Sclerosis Complex With Sleep Disorder Responsive to Melatonin

Department of Paediatrics Royal United Hospital Bath NHS Trust, and School for Health, University of Bath, Bath, UK

Finbar O'Callaghan, PhD

Department of Paediatrics Royal United Hospital Bath NHS Trust, and School for Health, University of Bath, Bath, UK

Judie English, PhD

Stockgrand Ltd School of Biological Sciences, University of Surrey, Surrey, UK

John P. Osborne, MD

Department of Paediatrics Royal United Hospital Bath NHS Trust, and School for Health, University of Bath, Bath, UK, mpsjpo{at}bath.ac.uk.

To determine normal melatonin excretion patterns in healthy children without sleep disorder and to compare these with those of patients with tuberous sclerosis complex and sleep disorder responsive to exogenous melatonin, we measured 6-sulfatoxymelatonin excretion in 21 healthy children and in 7 patients with tuberous sclerosis complex and sleep disorder responsive to melatonin (a 5 mg oral dose increasing total sleep time). Total excretion, cosinor percentage, and acrophase time of 6-sulfatoxymelatonin excretion were estimated. In normal children, total 6-sulfatoxymelatonin excretion was range 11.1 to 40.2 µg (mean 19.0 µg, SD 7.4 µg); cosinor percentage rhythm range was 52.9% to 100% (mean 87%, median 94%); and acrophase time range was 23 hours, 54 minutes to 10 hours, 42 minutes (mean 5 hours, 54 minutes; median 4 hours, 12 minutes). Fifth and 95th percentiles were 11.1 to 29.0 µg, 57.8% to 99.9%, and 2 hours, 1 minute to 10 hours, 4 minutes. In tuberous sclerosis, normal patterns of melatonin excretion were seen in responders. Circadian patterns of melatonin excretion were similar in children and adults. We propose that exogenous melatonin can act by a simple sedative action. (J Child Neurol 2005;20:21—25).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Hancock, F. O'Callaghan, and J. P. Osborne Effect of Melatonin Dosage on Sleep Disorder in Tuberous Sclerosis Complex J Child Neurol, January 1, 2005; 20(1): 78 - 80. [Abstract] [PDF]